A new study finds that a widely used antibiotic, azithromycin, may increase the likelihood of sudden death in adults, especially those who have heart disease or are at high risk for it

May 2012
MondayMorning;5/21/2012, Vol. 20 Issue 21, p1
The article discusses a study conducted by researcher Wayne A. Ray and colleagues which has found that antibiotic azithromycin may increase likelihood of sudden death in adults, especially those who have heart disease or are at high risk for it. It is evident that azithromycin is used to treat various bacterial infections. The study was published in the "New England Journal of Medicine."


Related Articles

  • Higher Dosages of Azithromycin Are More Effective in Treatment of Group A Streptococcal Tonsillopharyngitis. Casey, Janet R.; Pichichero, Michael E. // Clinical Infectious Diseases;6/15/2005, Vol. 40 Issue 12, p1748 

    Background. Azithromycin has become a frequent choice for the treatment of group A streptococcal (GAS) tonsillopharyngitis. In this study, our objective was to determine the optimal dose of azithromycin for treatment of GAS tonsillopharyngitis in children and adults by analyzing trials that used...

  • Macrolide-Resistant Shigella sonnei. Boumghar-Bourtchai, Leyla; Mariani-Kurkdjian, Patricia; Bingen, Edouard; Filliol, Ingrid; Dhalluin, Anne; Ifrane, Shadia Ait; Weill, François-Xavier; Leclercq, Roland // Emerging Infectious Diseases;Aug2008, Vol. 14 Issue 8, p1297 

    Shigella sonnei UCN59, isolated during an outbreak of S. sonnei in January 2007, was resistant to azithromycin (MIC 64 mg/L). The isolate contained a plasmid-borne mph(A) gene encoding a macrolide 2'-phosphotransferase that inactivates macrolides. Emergence of the mph(A) gene in S. sonnei may...

  • Antibiotic management.  // Thorax;May2002 Supplement 1, Vol. 57, pi16 

    The article discusses about the antibiotic treatment of children with community acquired pneumonia (CAP). There is lack of evidence for treatment with antibiotics. One of the major problems in deciding whether to treat a child with CAP with antibiotics is the difficulty in distinguishing...

  • Challenges in implementing the new BASHH guidelines for the management of gonorrhoea. Rodgers, S; Murgatroyd, M; Perez, K; Kingston, M; Lee, V // International Journal of STD & AIDS;Feb2014, Vol. 25 Issue 2, p145 

    Neisseria gonorrhoeae has progressively developed reduced sensitivity to different classes of antibiotics. The British Association for Sexual Health and HIV (BASHH) updated guidelines for the diagnosis and management of gonorrhoea in 2011. New recommendations include an increased dose of...

  • Clinical: Opportunistic chlamydia testing. Kalwij, Sebastian // GP: General Practitioner;3/19/2010, p43 

    The article focuses on the medical testing of chlamydia. There are three types of tests and all of them are very sensitive including a urine test for men, self-vaginal swab and endocervical swab for women. The treatment includes azithromycin unless the patient is pregnant or allergic to...

  • A Primer on …: Azithromycin. Simpson, Nova // Pediatrics for Parents;Jul/Aug2010, Vol. 26 Issue 7/8, p19 

    The article focuses on the essence of using Azithromycin for treating several infections in the U.S. It states that Azithromycin belongs to a group of antibiotics known as macrolides that prevents bacteria from multiplying. Moreover, Azithromycin is recommended for treatment in children and may...

  • Labeling and biological evaluation of Tc-azithromycin for infective inflammation diagnosis. Sanad, M. // Radiochemistry;Sep2013, Vol. 55 Issue 5, p539 

    Azithromycin, an antibiotic used to treat bacterial infections, was labeled with Tc. The maximum radiochemical yield of Tc-azithromycin, 97.5 ± 0.9%, was attained under the following conditions: addition of Tc to 2 mg of azithromycin in the presence of 50 μg of SnCl·2HO at pH 4,...

  • Treatment and prophylaxis of Mycobacterium avium complex. Young, L. S. // International Journal of STD & AIDS;Jan1996 Supplement 1, Vol. 7, p23 

    The most common pathogens involved in disseminated bacterial infection in people with acquired immunodeficiency syndrome (AIDS) are organisms of the Mycobacterium avium-intracellulare complex (MAC). Azithromycin and clarithromycin, a new azalide and macrolide, respectively, are among the most...

  • Complete Elimination Is a Difficult Goal for Trachoma Programs in Severely Affected Communities. Gill, Deborah A.; Lakew, Takele; Alemayehu, Wondu; Melese, Muluken; Zhaoxia Zhou; House, Jenafir I.; Hong, Kevin C.; Ray, Kathryn J.; Gandhi, Nandini; Whitcher, John P.; Gaynor, Bruce D.; Lietman, Thomas M. // Clinical Infectious Diseases;2/15/2008, Vol. 46 Issue 4, p564 

    The World Health Organization has distributed millions of doses of azithromycin to control the ocular chlamydial infection that causes trachoma. Theoretically, a loftier goal of elimination is feasible. Here, we demonstrate that, although local elimination of infection in the most severely...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics